These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 8346077

  • 21. Simultaneous and rapid determination of the anticarcinogenic proteins Bowman-Birk inhibitor and lectin in soybean crops by perfusion RP-HPLC.
    Anta L, Luisa Marina M, García MC.
    J Chromatogr A; 2010 Nov 05; 1217(45):7138-43. PubMed ID: 20889157
    [Abstract] [Full Text] [Related]

  • 22. Protection against adverse biological effects induced by space radiation by the Bowman-Birk inhibitor and antioxidants.
    Kennedy AR, Zhou Z, Donahue JJ, Ware JH.
    Radiat Res; 2006 Aug 05; 166(2):327-32. PubMed ID: 16881733
    [Abstract] [Full Text] [Related]

  • 23. Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro.
    Yavelow J, Collins M, Birk Y, Troll W, Kennedy AR.
    Proc Natl Acad Sci U S A; 1985 Aug 05; 82(16):5395-9. PubMed ID: 3860869
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia.
    Armstrong WB, Kennedy AR, Wan XS, Atiba J, McLaren CE, Meyskens FL.
    Cancer Epidemiol Biomarkers Prev; 2000 Jan 05; 9(1):43-7. PubMed ID: 10667462
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Antiapoptotic activity of the Bowman-Birk inhibitor can be attributed to copurified phospholipids.
    Foehr MW, Tomei LD, Goddard JG, Pemberton PA, Bathurst IC.
    Nutr Cancer; 1999 Jan 05; 34(2):199-205. PubMed ID: 10578488
    [Abstract] [Full Text] [Related]

  • 30. Bowman-Birk soybean protease inhibitor as an anticarcinogen.
    Yavelow J, Finlay TH, Kennedy AR, Troll W.
    Cancer Res; 1983 May 05; 43(5 Suppl):2454s-2459s. PubMed ID: 6682011
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.
    Chen YW, Huang SC, Lin-Shiau SY, Lin JK.
    Carcinogenesis; 2005 Jul 05; 26(7):1296-306. PubMed ID: 15746161
    [Abstract] [Full Text] [Related]

  • 33. Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment.
    Armstrong WB, Wan XS, Kennedy AR, Taylor TH, Meyskens FL.
    Laryngoscope; 2003 Oct 05; 113(10):1687-702. PubMed ID: 14520092
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia.
    Malkowicz SB, McKenna WG, Vaughn DJ, Wan XS, Propert KJ, Rockwell K, Marks SH, Wein AJ, Kennedy AR.
    Prostate; 2001 Jun 15; 48(1):16-28. PubMed ID: 11391683
    [Abstract] [Full Text] [Related]

  • 36. Bowman-Birk inhibitor and genistein among soy compounds that synergistically inhibit nitric oxide and prostaglandin E2 pathways in lipopolysaccharide-induced macrophages.
    Dia VP, Berhow MA, Gonzalez De Mejia E.
    J Agric Food Chem; 2008 Dec 24; 56(24):11707-17. PubMed ID: 19053380
    [Abstract] [Full Text] [Related]

  • 37. Probing the soybean Bowman-Birk inhibitor using recombinant antibody fragments.
    Muzard J, Fields C, O'Mahony JJ, Lee GU.
    J Agric Food Chem; 2012 Jun 20; 60(24):6164-72. PubMed ID: 22642722
    [Abstract] [Full Text] [Related]

  • 38. Negative growth control of osteosarcoma cell by Bowman-Birk protease inhibitor from soybean; involvement of connexin 43.
    Saito T, Sato H, Virgona N, Hagiwara H, Kashiwagi K, Suzuki K, Asano R, Yano T.
    Cancer Lett; 2007 Aug 18; 253(2):249-57. PubMed ID: 17343982
    [Abstract] [Full Text] [Related]

  • 39. Effects of the Bowman-Birk inhibitor on growth, invasion, and clonogenic survival of human prostate epithelial cells and prostate cancer cells.
    Kennedy AR, Wan XS.
    Prostate; 2002 Feb 01; 50(2):125-33. PubMed ID: 11816021
    [Abstract] [Full Text] [Related]

  • 40. Effects of spermine-conjugated Bowman-Birk inhibitor (spermine-BBI) on carcinogenesis and cholesterol biosynthesis in mice.
    Kennedy AR, Kritchevsky D, Shen WC.
    Pharm Res; 2003 Dec 01; 20(12):1908-10. PubMed ID: 14725352
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.